STOCK TITAN

[4] – Deese Willie A (CIK 0001328766)

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4

DENTSPLY SIRONA (XRAY) filed a Form 4 for director Willie A. Deese. On 10/10/2025, 179.449 restricted stock units were acquired at $0 under code A as dividend equivalents on existing RSUs. After this entry, beneficial ownership is 57,546.558 shares, held directly. These dividend RSUs follow the same vesting schedule as the underlying awards, with each RSU converting to common stock on a 1:1 basis.

DENTSPLY SIRONA (XRAY) ha presentato un Form 4 per il direttore Willie A. Deese. Il 10/10/2025, 179.449 unità di azioni vincolate sono state acquisite a $0 secondo il codice A come equivalenti a dividendi su RSU esistenti. Dopo questa entrata, la proprietà beneficio è 57.546.558 azioni, detenute direttamente. Queste RSU di dividendi seguono lo stesso calendario di vesting delle premi sottostanti, con ogni RSU che si converte in azioni ordinarie in base 1:1.

DENTSPLY SIRONA (XRAY) presentó un Form 4 para el director Willie A. Deese. El 10/10/2025, 179.449 unidades restringidas de acciones se adquirieron a $0 bajo el código A como equivalentes a dividendos sobre RSU existentes. Después de esta entrada, la titularidad beneficiosa es de 57.546.558 acciones, detenidas directamente. Estas RSU de dividendos siguen el mismo calendario de vesting que los premios subyacentes, con cada RSU convirtiéndose en acciones comunes en una base 1:1.

DENTSPLY SIRONA (XRAY) 이사는 Willie A. Deese를 위한 Form 4를 제출했습니다. 2025년 10월 10일, 179.449 제한 주식 단위가 코드 A에 따라 기존 RSU에 대한 배당 등가물로서 $0에 취득되었습니다. 이 기록 이후, 실질 소유권은 57.546.558주로 직접 보유됩니다. 이 배당 RSU는 기저 보상과 동일한 베스팅 일정에 따르며, 각 RSU는 1:1 비율로 보통주로 전환됩니다.

DENTSPLY SIRONA (XRAY) a déposé un Form 4 pour le administrateur Willie A. Deese. Le 10/10/2025, 179.449 unités d'actions restreintes ont été acquises à $0 dans le cadre du code A en tant qu'équivalents à des dividendes sur les RSU existants. Après cette entrée, la propriété bénéficiaire est de 57.546.558 actions, détenues directement. Ces RSU de dividendes suivent le même calendrier de vesting que les titres sous-jacents, chaque RSU se convertissant en actions ordinaires sur une base 1:1.

DENTSPLY SIRONA (XRAY) legte für den Direktor Willie A. Deese ein Form 4 vor. Am 10.10.2025 wurden 179.449 Restricted Stock Units zu $0 gemäß Code A als Dividendenäquivalente zu bestehenden RSUs erworben. Nach diesem Eintrag beträgt die begünstigte Eigentümerschaft 57.546.558 Aktien, direkt gehalten. Diese Dividend-RSUs folgen demselben Vesting-Zeitplan wie die zugrunde liegenden Awards, wobei jede RSU 1:1 in Stammaktien umgewandelt wird.

DENTSPLY SIRONA (XRAY) قدمت نموذج Form 4 للمدير Willie A. Deese. في 10/10/2025، تم شراء 179.449 وحدة أسهم مقيدة بموجب الرمز A كمعادلات توزيعات على RSUs القائمة بسعر $0. بعد هذا الإدخال، تبلغ الملكية المفيدة 57.546.558 سهماً، مملوكة مباشرة. تتبع هذه RSUs التوزيعية نفس جدول الاستحقاق كالمكافآت الأساسية، مع تحويل كل RSU إلى أسهم عادية بنسبة 1:1.

DENTSPLY SIRONA (XRAY) 已为董事 Willie A. Deese 提交 Form 4。日期为 2025-10-10,179.449 份受限股票单位在代码 A 下以 $0 作为对现有 RSU 的股息等值被获得。经此项记录后,受益所有权为 57.546.558 股,直接持有。这些股息 RSU 遵循与基础奖励相同的归属时间表,每个 RSU 以 1:1 的比例转换为普通股。

Positive
  • None.
Negative
  • None.

DENTSPLY SIRONA (XRAY) ha presentato un Form 4 per il direttore Willie A. Deese. Il 10/10/2025, 179.449 unità di azioni vincolate sono state acquisite a $0 secondo il codice A come equivalenti a dividendi su RSU esistenti. Dopo questa entrata, la proprietà beneficio è 57.546.558 azioni, detenute direttamente. Queste RSU di dividendi seguono lo stesso calendario di vesting delle premi sottostanti, con ogni RSU che si converte in azioni ordinarie in base 1:1.

DENTSPLY SIRONA (XRAY) presentó un Form 4 para el director Willie A. Deese. El 10/10/2025, 179.449 unidades restringidas de acciones se adquirieron a $0 bajo el código A como equivalentes a dividendos sobre RSU existentes. Después de esta entrada, la titularidad beneficiosa es de 57.546.558 acciones, detenidas directamente. Estas RSU de dividendos siguen el mismo calendario de vesting que los premios subyacentes, con cada RSU convirtiéndose en acciones comunes en una base 1:1.

DENTSPLY SIRONA (XRAY) 이사는 Willie A. Deese를 위한 Form 4를 제출했습니다. 2025년 10월 10일, 179.449 제한 주식 단위가 코드 A에 따라 기존 RSU에 대한 배당 등가물로서 $0에 취득되었습니다. 이 기록 이후, 실질 소유권은 57.546.558주로 직접 보유됩니다. 이 배당 RSU는 기저 보상과 동일한 베스팅 일정에 따르며, 각 RSU는 1:1 비율로 보통주로 전환됩니다.

DENTSPLY SIRONA (XRAY) a déposé un Form 4 pour le administrateur Willie A. Deese. Le 10/10/2025, 179.449 unités d'actions restreintes ont été acquises à $0 dans le cadre du code A en tant qu'équivalents à des dividendes sur les RSU existants. Après cette entrée, la propriété bénéficiaire est de 57.546.558 actions, détenues directement. Ces RSU de dividendes suivent le même calendrier de vesting que les titres sous-jacents, chaque RSU se convertissant en actions ordinaires sur une base 1:1.

DENTSPLY SIRONA (XRAY) legte für den Direktor Willie A. Deese ein Form 4 vor. Am 10.10.2025 wurden 179.449 Restricted Stock Units zu $0 gemäß Code A als Dividendenäquivalente zu bestehenden RSUs erworben. Nach diesem Eintrag beträgt die begünstigte Eigentümerschaft 57.546.558 Aktien, direkt gehalten. Diese Dividend-RSUs folgen demselben Vesting-Zeitplan wie die zugrunde liegenden Awards, wobei jede RSU 1:1 in Stammaktien umgewandelt wird.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
Deese Willie A

(Last) (First) (Middle)
C/O DENTSPLY SIRONA INC
13320-B BALLANTYNE CORPORATE PLACE

(Street)
CHARLOTTE NC 28277

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
DENTSPLY SIRONA Inc. [ XRAY ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
10/10/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 10/10/2025 A 179.449(1) A $0 57,546.558 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Represents dividends on restricted stock units (RSUs) awarded to the Reporting Person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis.
/s/ Jessica Nielsen Causey, Attorney-in-Fact for Willie A. Deese 10/15/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did XRAY report on Form 4?

On 10/10/2025, director Willie A. Deese acquired 179.449 RSUs at $0 under code A.

Why were the XRAY RSUs acquired at $0?

They represent dividends on existing RSUs, issued as additional RSUs with no cash price.

How many XRAY shares does the insider own after the transaction?

Beneficial ownership is 57,546.558 shares, held directly.

What does code A mean in this XRAY Form 4?

Code A indicates an acquisition, here reflecting RSU dividend equivalents.

How do the dividend RSUs vest for XRAY?

They vest simultaneously with the underlying RSU awards and convert 1:1 into common stock.

What is the reporting person's role at XRAY?

Willie A. Deese is a Director of DENTSPLY SIRONA Inc.
Dentsply Sirona Inc

NASDAQ:XRAY

XRAY Rankings

XRAY Latest News

XRAY Latest SEC Filings

XRAY Stock Data

2.52B
198.69M
0.39%
104.2%
3.83%
Medical Instruments & Supplies
Dental Equipment & Supplies
Link
United States
CHARLOTTE